Malaysian (KLSE) Pharma Industry Analysis
UpdatedJun 26, 2022
DataAggregated Company Financials
Companies6
- 7D-3.2%
- 3M-11.9%
- 1Y-25.5%
- YTD-9.9%
Over the last 7 days, the Pharma industry has dropped 3.2%, driven by pullbacks in Duopharma Biotech Berhad and Apex Healthcare Berhad of 5.1% and 3.6%, respectively. The industry has fallen 26% in the last year. Looking forward, earnings are forecast to grow by 6.7% annually.
Industry Valuation and Performance
Has the Malaysian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Sun, 26 Jun 2022 | RM3.4b | RM2.3b | RM226.0m | 13.9x |
| Tue, 24 May 2022 | RM4.0b | RM2.3b | RM215.3m | 14.4x |
| Thu, 21 Apr 2022 | RM4.0b | RM2.2b | RM204.5m | 16.3x |
| Sat, 19 Mar 2022 | RM3.7b | RM2.2b | RM204.5m | 16.1x |
| Mon, 14 Feb 2022 | RM3.8b | RM2.1b | RM187.4m | 16.3x |
| Wed, 12 Jan 2022 | RM3.7b | RM2.1b | RM187.4m | 15.3x |
| Fri, 10 Dec 2021 | RM3.7b | RM2.1b | RM187.4m | 15.2x |
| Sun, 07 Nov 2021 | RM3.8b | RM2.0b | RM166.6m | 20.4x |
| Tue, 05 Oct 2021 | RM3.9b | RM2.0b | RM166.6m | 20.8x |
| Thu, 02 Sep 2021 | RM4.2b | RM2.0b | RM166.5m | 21.9x |
| Sat, 31 Jul 2021 | RM4.2b | RM2.0b | RM166.5m | 19.5x |
| Tue, 04 May 2021 | RM4.3b | RM2.0b | RM167.4m | 18.2x |
| Fri, 05 Feb 2021 | RM5.1b | RM1.9b | RM169.0m | 24.1x |
| Mon, 09 Nov 2020 | RM5.1b | RM2.0b | RM169.6m | 17.4x |
| Sun, 02 Aug 2020 | RM4.4b | RM2.0b | RM180.8m | 16.6x |
| Wed, 06 May 2020 | RM2.9b | RM2.0b | RM175.1m | 13x |
| Sat, 08 Feb 2020 | RM2.9b | RM1.9b | RM169.7m | 14.1x |
| Fri, 01 Nov 2019 | RM2.8b | RM1.9b | RM173.6m | 13.9x |
| Mon, 05 Aug 2019 | RM2.7b | RM1.9b | RM170.8m | 14.7x |
Median PE Ratio
14.7x
Current Industry PE
- Investors are pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 15.1x which is lower than its 3-year average PE of 21.7x.
- The industry's 3-year average PS ratio 1.9x is higher than the industry's current PS ratio of 1.5x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 9.8% per year over the last three years.
- Revenues for these companies have grown 7.1% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Malaysian Pharma compare with similar industries?
| MY Market | -1.16% | |
| Healthcare | 1.25% | |
| Pharma | -3.23% | |
| Pharma | -3.23% | |
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| YSPSAH Y.S.P. Southeast Asia Holding Berhad | RM1.99 | 3.6% +RM10.0m | -8.3% | PS14.8x |